Next Financial Group’s Amneal Pharmaceuticals AMRX Stock Holding History

Next Financial Group’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$14K	Sell	3,000 -3,300	-52%	-$16.5K	﹤0.01%	2027
2021 Q3	$34K	Sell	6,300 -500	-7%	-$2.52K	﹤0.01%	1573
2021 Q2	$35K	Sell	6,800 -2,000	-23%	-$11.4K	﹤0.01%	1528
2021 Q1	$59K	Buy	8,800 +2,000	+29%	+$11.1K	0.01%	1215
2020 Q4	$31K	Hold	6,800	–	–	﹤0.01%	1367
2020 Q3	$26K	Sell	6,800 -4,300	-39%	-$18.4K	﹤0.01%	1312
2020 Q2	$53K	Sell	11,100 -200	-2%	-$824	0.01%	589
2020 Q1	$39K	Buy	11,300 +3,500	+45%	+$14.8K	0.01%	1063
2019 Q4	$38K	Buy	+7,800	New	+$27.1K	﹤0.01%	1293

Other funds holding AMRX

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Next Financial Group's AMRX Position: Q4 2021 in Review

Next Financial Group reduced its Amneal Pharmaceuticals (AMRX) stake by 52% in Q4 2021, selling an estimated $16.5K and leaving 3,000 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #2027.

Next Financial Group first reported a position in AMRX in Q4 2019 and has held it in 9 quarters since. The position peaked at $59K in Q1 2021. 154 funds tracked by Wall St. Rank hold AMRX as of Q4 2021.

Next Financial Group held 3,000 shares of Amneal Pharmaceuticals worth $14K as of Q4 2021.
Next Financial Group sold 3,300 Amneal Pharmaceuticals shares in Q4 2021, an estimated $16.5K.
Amneal Pharmaceuticals made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2027 holding.
Next Financial Group first reported a position in Amneal Pharmaceuticals in Q4 2019 and has held it in 9 quarters since.
Next Financial Group's Amneal Pharmaceuticals position peaked at $59K in Q1 2021.
154 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.